Are you looking quote for part NDC47781-0200-50? The Alvogen-manufactured component (CAGE Code: 6K8D6) is documented under NSN 6505-00-912-7457 as Melphalan Tablets. For the fastest quote, please complete our RFQ form with details about NDC47781-0200-50. We guarantee a response within 15 minutes.
ASAP Components provides the verified NDC47781-0200-50, classified under INC 27584, FSG , FSC , NIIN 00-912-7457, and NCB 00. Submit your requirements today to receive immediate pricing and availability information.
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-00-912-7457 Item PartTypeName: MELPHALAN TABLETS | 6505 | 009127457 | F | Y | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| U | A | |||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| NDC47781-0200-50 | 5 | 2 | 3 |
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 MILLIGRAMS MELPHALAN ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 50.000 TABLETS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | MELPHALAN TABLETS USP 2MG 50S BT |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| End Use : 40100 | Pharmaceutical preparations |
|---|---|
| Schedule B : 3004909115 (NAICS 325412) | Antineoplastic and immunosupressive medicaments put up in measured doses or in forms or packings for retail sale |
| SITC : 54293 | Medicaments, n.E.S., in dosage form or retail packings |
| CRITL | The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. |
|---|---|
| HMIC | Y - Indicates information is in the hazardous materials information resource system (hmirs). |
| PMIC | A - Item does not contain precious metal. |
| AAC | L |
|---|---|
| Classification Control | U |
| MGMT_CTL | C2201x- |
| Quantity per pack | 1 |
| Repariability | |
| Shelf Life | 6 mo. |
| SOS | Sms |
| Unit of Measure | Bt |
